Goldline Plus Weight Loss Medication

Goldline Plus weight loss medication, manufactured by Izvarino, Russia, and identified by EAN 4660007703142, is a medication containing the active ingredient sibutramine. It is designed to help treat obesity and support weight loss efforts in overweight individuals.

Main Uses:

• Excess Weight and Obesity: Goldline Plus is used for weight loss in adults with a body mass index (BMI) of 30 kg/m² or higher, or those with a BMI of 27 kg/m² or higher who have conditions like type 2 diabetes or high cholesterol.
• Appetite Control: This medication helps reduce appetite and feelings of hunger, making it easier to follow a low-calorie diet and control food intake.
• Improved Metabolism: Goldline Plus can enhance metabolic processes, helping to burn fat more effectively and reduce fat accumulation.
• Preventing Obesity Complications: Weight loss achieved with Goldline Plus may lower the risk of obesity-related complications like heart disease, diabetes, and high blood pressure.
• Maintaining Achieved Weight: It can help maintain weight after initial weight loss to prevent regaining lost weight.

Goldline Plus should only be taken under a doctor’s supervision, alongside a diet and exercise plan. The recommended starting dose is typically 10 mg of sibutramine once daily. If weight loss is less than 2 kg after 4 weeks, the dose may be increased to 15 mg daily. Treatment should not continue for more than 3 months if the patient does not lose at least 5% of their initial body weight during that time. The maximum treatment duration is 1 year, as there is no data on the safety and effectiveness of longer use.

Goldline Plus (sibutramine/microcrystalline cellulose) is a combination anti-obesity medication. Sibutramine promotes weight loss via central serotonergic and adrenergic effects that increase satiety and thermogenesis. Microcrystalline cellulose provides non-specific detoxification through enterosorbent activity. After oral dosing, sibutramine undergoes extensive first-pass hepatic metabolism to active metabolites with elimination half-lives of 14-16 hours. Steady-state is reached within 4 days of repeated dosing.

Goldline Plus requires medical supervision as part of a comprehensive weight management program involving dietary, exercise, and behavioral modifications. It is contraindicated in various cardiovascular, psychiatric, and substance abuse disorders. Common adverse effects include dry mouth, insomnia, headache, nausea, and constipation. Sibutramine may increase heart rate and blood pressure, requiring regular monitoring. Drug interactions exist with CYP3A4 inhibitors/inducers and serotonergic agents. Treatment duration should not exceed 1 year due to limited long-term safety data. Appropriate patient selection, clinical monitoring, and lifestyle counseling are essential for safe and effective use of this medication.

Additional Information:

• Product Name (INN): Goldline Plus
• Manufacturer: Izvarino, Russia
• EAN: 4660007703142
• Expiry Date: Dec 2026
• Active Ingredient: Sibutramin 10 mg

Usage Instructions: Please read the instructions carefully before use. Goldline Plus weight loss medication should be used as directed by a healthcare professional.

Keywords: Goldline Plus Weight Loss Medication, sibutramine for obesity, appetite control medication, weight management support, obesity treatment, metabolic improvement, preventing obesity complications, maintaining weight loss, safe weight loss medication, effective weight loss solution.

Achieve your weight loss goals with Goldline Plus weight loss medication. Available now at the Russian Pharmacy in the USA, Goldline Plus is your partner in effective and safe weight management.